Cargando…

Antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review

BACKGROUND: The prevalence of obesity is increasing worldwide, and there is growing interest in better delineating the role of the human gut microbiome in this phenomenon. Obesity-specific gut microbiome features have been observed in both human and animal studies, and these variations appear to pla...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutton, Heidi, Doyle, Mary-Anne, Buchan, C. Arianne, Mohammad, Shuhiba, Adamo, Kristi B., Shorr, Risa, Fergusson, Dean A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571496/
https://www.ncbi.nlm.nih.gov/pubmed/28837004
http://dx.doi.org/10.1186/s13643-017-0565-9
_version_ 1783259350720053248
author Dutton, Heidi
Doyle, Mary-Anne
Buchan, C. Arianne
Mohammad, Shuhiba
Adamo, Kristi B.
Shorr, Risa
Fergusson, Dean A.
author_facet Dutton, Heidi
Doyle, Mary-Anne
Buchan, C. Arianne
Mohammad, Shuhiba
Adamo, Kristi B.
Shorr, Risa
Fergusson, Dean A.
author_sort Dutton, Heidi
collection PubMed
description BACKGROUND: The prevalence of obesity is increasing worldwide, and there is growing interest in better delineating the role of the human gut microbiome in this phenomenon. Obesity-specific gut microbiome features have been observed in both human and animal studies, and these variations appear to play a causative role in increasing body weight. There is evidence that antibiotics can modify the composition and diversity of the gut microbiome and that this may contribute to body weight changes. The primary objective of the proposed systematic review is to evaluate and synthesize the existing evidence evaluating the possible association between antibiotic use, weight gain, and obesity. METHODS: A comprehensive search of the MEDLINE and EMBASE databases will be performed. Both randomized and non-randomized studies (excluding case reports) in neonates, children, adults, and pregnant women will be included. The exposure of interest is antibiotics of any type, duration, and route given for any indication. All included studies must have a comparator group. The primary outcomes are the development of overweight and obesity. Secondary outcomes are percent weight-change from baseline and change in body mass index or waist circumference. Additional secondary outcomes in pregnant women are gestational weight gain, postpartum weight retention, offspring birth weight, childhood weight, and obesity. Risk of bias of included trials will be performed. Two reviewers will screen and perform data extraction independently. DISCUSSION: This systematic review will summarize the existing evidence evaluating the association between antibiotic use, weight gain, and obesity and facilitate the identification of important gaps and uncertainties in the literature. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42017069177 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13643-017-0565-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5571496
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55714962017-08-29 Antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review Dutton, Heidi Doyle, Mary-Anne Buchan, C. Arianne Mohammad, Shuhiba Adamo, Kristi B. Shorr, Risa Fergusson, Dean A. Syst Rev Protocol BACKGROUND: The prevalence of obesity is increasing worldwide, and there is growing interest in better delineating the role of the human gut microbiome in this phenomenon. Obesity-specific gut microbiome features have been observed in both human and animal studies, and these variations appear to play a causative role in increasing body weight. There is evidence that antibiotics can modify the composition and diversity of the gut microbiome and that this may contribute to body weight changes. The primary objective of the proposed systematic review is to evaluate and synthesize the existing evidence evaluating the possible association between antibiotic use, weight gain, and obesity. METHODS: A comprehensive search of the MEDLINE and EMBASE databases will be performed. Both randomized and non-randomized studies (excluding case reports) in neonates, children, adults, and pregnant women will be included. The exposure of interest is antibiotics of any type, duration, and route given for any indication. All included studies must have a comparator group. The primary outcomes are the development of overweight and obesity. Secondary outcomes are percent weight-change from baseline and change in body mass index or waist circumference. Additional secondary outcomes in pregnant women are gestational weight gain, postpartum weight retention, offspring birth weight, childhood weight, and obesity. Risk of bias of included trials will be performed. Two reviewers will screen and perform data extraction independently. DISCUSSION: This systematic review will summarize the existing evidence evaluating the association between antibiotic use, weight gain, and obesity and facilitate the identification of important gaps and uncertainties in the literature. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42017069177 ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13643-017-0565-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-08-24 /pmc/articles/PMC5571496/ /pubmed/28837004 http://dx.doi.org/10.1186/s13643-017-0565-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Protocol
Dutton, Heidi
Doyle, Mary-Anne
Buchan, C. Arianne
Mohammad, Shuhiba
Adamo, Kristi B.
Shorr, Risa
Fergusson, Dean A.
Antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review
title Antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review
title_full Antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review
title_fullStr Antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review
title_full_unstemmed Antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review
title_short Antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review
title_sort antibiotic exposure and risk of weight gain and obesity: protocol for a systematic review
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571496/
https://www.ncbi.nlm.nih.gov/pubmed/28837004
http://dx.doi.org/10.1186/s13643-017-0565-9
work_keys_str_mv AT duttonheidi antibioticexposureandriskofweightgainandobesityprotocolforasystematicreview
AT doylemaryanne antibioticexposureandriskofweightgainandobesityprotocolforasystematicreview
AT buchancarianne antibioticexposureandriskofweightgainandobesityprotocolforasystematicreview
AT mohammadshuhiba antibioticexposureandriskofweightgainandobesityprotocolforasystematicreview
AT adamokristib antibioticexposureandriskofweightgainandobesityprotocolforasystematicreview
AT shorrrisa antibioticexposureandriskofweightgainandobesityprotocolforasystematicreview
AT fergussondeana antibioticexposureandriskofweightgainandobesityprotocolforasystematicreview